Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-047756

Director sold 5,000 shares at $3.70 ($18,500)

  • Director acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Johnston John Joseph Director 2023-08-28 Option exercise 10b5-1 +100 $1.64 $164 120,683 D
Johnston John Joseph Director 2023-08-28 Sale 10b5-1 −100 $3.70 $370 120,583 D
Johnston John Joseph Director 2023-08-29 Option exercise 10b5-1 +2,059 $1.64 $3,379 122,642 D
Johnston John Joseph Director 2023-08-29 Sale 10b5-1 −2,059 $3.70 $7,618 120,583 D
Johnston John Joseph Director 2023-08-30 Option exercise 10b5-1 +2,841 $1.64 $4,662 123,424 D
Johnston John Joseph Director 2023-08-30 Sale 10b5-1 −2,841 $3.70 $10,512 120,583 D
Derivatives
Johnston John Joseph Director 2023-08-28 Option exercise · Stock Option (right to buy) 10b5-1 −100 13,617 D
Johnston John Joseph Director 2023-08-29 Option exercise · Stock Option (right to buy) 10b5-1 −2,059 11,558 D
Johnston John Joseph Director 2023-08-30 Option exercise · Stock Option (right to buy) 10b5-1 −2,841 8,717 D
Open-market sales · 5,000 sh · avg $3.70 · $18,500
Loading xslF345X05/doc4.xml…